|
- hypersensitivity to sulpiride or to one of the other ingredients of Dogmatil
- prolactin-dependent tumours (eg, pituitary gland prolactinomas and breast cancer)
- known or suspected pheochromocytoma
- in combination with sultopride, dopamine agonists (amantadine, apomorphine, bromocriptine, cabergoline, entacapone, lisuride, pergolide, piribedil, pramipexole, quinagolide, ropinirole) apart from in patients with Parkinson' s disease
- breastfeeding
- in combination with alcohol and levodopa
- medicinal products liable to induce torsade de pointes
- certain neuroleptics (thioridazine, chlorpromazine, levomepromazine, trifluoperazine, cyamemazine, amisulpride, tiapride, pimozide, haloperidol, droperidol), and other medicinal products eg, bepridil, cisapride, diphemanil, erythromycin IV, mizolastine, vincamine IV, halofantrine, pentamidine, sparfloxacin, moxifloxacin, etc
- dopamine agonists (amantadine, apomorphine, bromocriptine, cabergoline, entacapone, lisuride, pergolide, piribedil, pramipexole, quinagolide, ropinirole) in patients with Parkinson' s disease
Dogmatil 50: Due to the presence of lactose, Dogmatil 50 is contraindicated in the event of congenital galactosaemia, glucose/galactose malabsorption syndrome or lactase deficiency
|